Hydroxyurea
Code | Size | Price |
---|
TAR-T0676-500mg | 500mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0676-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0676-1g | 1g | £113.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Hydroxyurea, an antineoplastic agent, inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
CAS:
127-07-1
Formula:
CH4N2O2
Molecular Weight:
76.055
Pathway:
Cell Cycle/Checkpoint; Apoptosis; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome; Autophagy
Purity:
0.9992
SMILES:
NC(=O)NO
Target:
Apoptosis; HIV Protease; DNA/RNA Synthesis; Autophagy
References
1. Lori F, et al. Clin Infect Dis. 2000, 30 Suppl 2:S193-7.
2. Zala C, et al. Clin Infect Dis. 2000, Suppl 2:S143-50.
3. Watanapokasin Y, et al. Exp Hematol. 2005, 33(12):1486-92.
4. Boucher PD, et al. Gene Ther. 2002, 9(15):1023-30.
5. Lebensburger JD, et al. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica. 2010 Sep;95(9):1599-603.